[…] Canadians until the Salk vaccine was introduced in 1955. From the Canadian Public Health Association review the story of polio. News. WHO says Ebola situation in DRC shows promise. News. CPE are on the rise worldwide. USA guidelines recommend screening for asymptomatic carriers on admission. This study evaluated the benefit of serial screens of CPE and other antibiotic-resistant Gram-negative bacteria...
Type: Post
All exhibitor information can be downloaded in one PDF document. Update: Driving to the conference? You can get free parking by booking your parking here. Exhibitor table locations are shown in the floorplan below. If you have visited this page before, please refresh your browser to ensure you are looking at the most recent version of the floorplan; the version you should see is dated...
Type: Page
[…] on soldiers and noted its tendency to kill bone marrow and suppress white blood cell production. 11 The breakthrough realization about the potential for using nitrogen mustard in cancer treatment, however, did not come until World War II, when the US government asked researchers at Yale School of Medicine in New Haven, Connecticut, to study potential antidotes to mustard gas as a weapon....
Type: Media
[…] et al. N Engl J Med 2006;355:2725-32 . Importance of "WHY?" 5 5 Evidence can be Highly Influential 6 6 Best practices must already be happening …Right? 7 7 8 Daily News, 2012 8 Real World Example 9 9 Common Barriers to Evidence-Based Practice Individual Level & System Level Knowledge/Education Low prioritization Time Resources Culture 10 Melnyk BM, et al. J Nurs Adm 2012;42(9): 410-7. Jun...
Type: Media
[…] influenza, and respiratory syncytial virus (RSV). This transition aligns with the following announcements and changes: Policy_Communique_Infection_Prevention_Control_Measures_Respiratory_Illness BC Ministry of Health (Oct 13, 2023) Actions protect people, B.C. communities this respiratory illness season | BC Gov News (Sep 28, 2023) After BC Ministry of Health approval of revised materials, the COVID-19 information is being removed from the BCCDC COVID-19 Infection Control webpage and updated materials...
Type: Post
[…] PICNet’s Community of Practice who may not otherwise have access through th eir employers. Webber Training is an international lecture series on topics of interest to infection contro l professionals and other health care professionals worldwide. A total of 52 training sessions were s ponsored by PICNet between March 2008 and March 2009. PICNet will continue to work closely with all Health Authorities and infection control professionals...
Type: Media
[…] PICNet’s Community of Practice who may not otherwise have access through th eir employers. Webber Training is an international lecture series on topics of interest to infection contro l professionals and other health care professionals worldwide. A total of 52 training sessions were s ponsored by PICNet between March 2008 and March 2009. PICNet will continue to work closely with all Health Authorities and infection control professionals...
Type: Media
[…] be substantiated. 60 For a discussion on nanosilver technologies, please see the NCCEH contracted review by Green and Ndegwa (2011) titled: 9 Nanotechnology: A Review of Exposure, Health Risks, and Recent Regulatory Developments .63 The World Health Organization (WHO) has suggested that the NOAEL of silver in drinking water to be 10 g consumed over a lifetime (i.e., daily ingestion of 2 L of water...
Type: Media
[…] Management of Health Care Providers who are Co ntacts of a Case ...
Type: Media
Methicillin -Resistant Staphylococcus aureus (MRSA) Surveillance Report For the Fiscal Year 201 3/20 14 (April 1, 201 3 to March 31, 201 4) Prepared by: Provincial Infection Control Network of British Columbia (PICNet) September 201 4 Provincial Infection Control Network of BC (PICNet) 1001 West Broadway, Suite 504 Vancouver, BC, V6H 4B1 www.picnet.ca Fax: 604 -875 -4373 Tel: 604 -875 -4844 ext 22983 Email: picnet@phsa.ca Disclaim er The...
Type: Media
[…] associated infections surveillance report Methicillin-resistant Staphylococcus aureus (MRSA) Update, Q2 2014/2015 December 2014 Summary Table Q2 2014/2015 Previous quarter Last 4 quarters Total new MRSA cases identified 734 610 2,683 Number of MRSA associated with the reporting facility 400 287 1,408 Total inpatient days 702,236 698,855 3,099,292 Provincial rate (95% CI) per 10,000 inpatient days 5.7 (5.2-6.3) 4.1 (3.7- 4.6) 4.5 (4.3- 4.8) Highlights • <mark...
Type: Media
[…] infections surveillance report Methicillin-resistant Staphylococcus aureus (MRSA) Update, Q 3 2014/2015 March 2015 Summary Table Q3 2014/2015 Previous quarter Last 4 quarters Total new MRSA cases identified 686 734 2,778 Number of MRSA associated with the reporting facility 335 400 1,459 Total inpatient days 757 ,058 702,236 3,106 ,827 Provincial rate per 10,000 inpatient days (95% CI) 4.4 ( 4.0 -4 .9 ) 5.7 (5.2 -6.3)...
Type: Media
Healthcare‐associated infections surveillance report Methicillin‐resistant Staphylococcus aureus (MRSA) Update, Q4 2014/2015 August 2015 Summary Table Q4 2014/2015 Previous quarter Last 4 quarters Total new MRSA cases identified 1,082 689 2,847 Number of MRSA associated with the reporting facility 537 333 1,453 Total inpatient days 1,014,015 757,100 3,142,728 Provincial rate per 10,000 inpatient days (95% CI) 5.3 (4.9‐5.8) 4.4 (4.0‐4.9) 4.6 (4.4‐4.9) Highlights The provincial rate of new cases of MRSA associated with the reporting facility in Q4 of 2014/2015 was significantly higher than in the previous quarter (Q3 of 2014/2015) and the last four quarters (Q4 of 2013/2014 – Q3 of 2014/2015). The provincial rate of MRSA fluctuated greatly in the past four quarters. The health authorities have been closely monitoring the trends of MRSA in their facilities. The provincial MRSA surveillance program was established to monitor the incidence and trends of healthcare‐ associated MRSA (either colonization or infection) among patients who have been hospitalized in acute care facilities. MRSA stands for Methicillin‐resistant Staphylococcus aureus, a type of S. aureus that has become resistant to certain antibiotics such as methicillin, penicillin, amoxicillin, etc., and is thus more difficult to treat. Like non‐ resistant S. aureus, MRSA often lives on the skin or in the nose of healthy people without causing symptoms (this is called colonization). It can, however, cause skin and other infections. Most infections are minor, such as pimples and boils. Serious infections — such as wound infections, pneumonia, or septicaemia (infections getting into the bloodstream) — can result in life‐threatening illness or, on rare occasions, death, if left untreated. Those with weakened immune systems and chronic illnesses are more susceptible to developing an infection. MRSA is primarily spread by skin‐to‐skin contact or through contact with items contaminated with the bacteria. It has been shown to spread easily in healthcare settings, therefore hospital patients, and residents in nursing homes or long‐term care facilities, are at a higher risk of acquiring MRSA. In addition, MRSA has been found in community settings. Hand hygiene is the most important measure to prevent the spread of MRSA in both <mark...
Type: Media
[…] Methicillin-resistant Staphylococcus aureus (MRSA) Update, Q 1 201 5/2016 October 2015 Summary Table Q1 201 5/2016 Previous quarter Last 4 quarters Total of new MRSA cases identified 751 1,082 3,130 Number of MRSA associated with the reporting facility 357 537 1,552 Total inpatient days 698,000 1,014,015 3,168,476 Provincial rate per 10,000 inpatient days (95% CI) 5.1 (4.6 -5.7) 5.3 (4.9- 5.8) 4.9 (4.7- 5.1) Note: <mark...
Type: Media
[…] December 2015 Summary Table Q 2 201 5/1 6 Previous quarter (Q1 of 2015/16) Same quarter of previous year (Q2 2014/15 ) Total CDI cases identified 658 637 471 Number of new CDI associated with the reporting facility 326 339 242 Total inpatient days 653,030 649,497 650,436 Provincial rate per 10,000 inpatient days (95% CI) 5.0 ( 4.5-5.6) 5.2 (4.7- 5.8) 3.7 ( 3.3 -4.2) Highlights...
Type: Media
[…] /16 December 2015 Summary Table Q2 201 5/2016 Previous quarter (Q1 of 2015 /16) Same quarter of previous year (Q2 2014/15 ) Total new MRSA cases identified 747 754 759 Number of MRSA associated with the reporting facility 343 359 399 Total inpatient days 702,099 697,031 700,279 Provincial rate per 10,000 inpatient days (95% CI) 4.9 (4.4- 5.4) 5.2 (4.6 -5.7) 5.7 ( 5 .2 -6...
Type: Media
[…] 2016 Summary Table Q4 201 5/1 6 Previous quarter (Q 3 201 5/16) Same quarter of previous year (Q4 2014/15 ) Total CDI cases identified 952 646 831 Number of new CDI cases associated with the reporting facility 465 311 465 Total inpatient days 973 ,558 691,550 946 ,826 Rate of CDI associated with the reporting facility per 10,000 inpatient days (95% CI) 4.8 (4.4...
Type: Media
[…] Table Q3 201 6/1 7 Previous quarter (Q2 2016/17) Same quarter of previous year (Q3 2015/16) Year -to- date 2016/17 Total CDI cases identified 522 524 646 1,621 Number of new CDI cases associated with the reporting facility 263 248 311 795 Total inpatient days 667,937 646,601 691,550 1,925,864 Rate of CDI associated with the reporting facility per 10,000 inpatient days (95% CI) 3.9 (3.5...
Type: Media
[…] 7 Highlights for Q 1 20 17/1 8 (April 1 – June 16 , 2017 ) 40 new cases of CPO were identified among 35 patients in BC acute care facilities NDM was the most common gene identified (27 /40 cases, 67.5 %) 31 cases (77.5%) reported healthcare exposure outside Canada . N o known risk factors were observed among 4 case s...
Type: Media
[…] antimicrobial resistance and antimicrobial stewardship programs (ASPs) Describe nurses’ involvement in ASPs Results from a multisite qualitative that aimed to explore barriers and facilitators to nurse -driven antibiotic stewardship Antimicrobial Resistance •Organisms develop resistance to the antibiotics designed to kill them • Unnecessary antibiotic use = major cause of antibiotic resistance • Approximately 55% of antibiotics are unnecessary or inappropriate (CDC) • Global and national public...
Type: Media